Therapy of Angiosarcoma with Thalidomide and Lenalidomide
Angiosarcoma is an uncommon malignancy with a poor prognosis. Systemic therapy options for patients with metastatic disease generally have limited effectiveness. In this case study, a 73-year-old male with metastatic angiosarcoma who previously declined chemotherapy and developed progressive disease...
Guardado en:
Autores principales: | M. Jules Mattes, Jeffrey A. Mattes, Roman Groisberg, Malcolm D. Mattes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Karger Publishers
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11781034e0c34366bdad1c958c3619c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deep Vein Thrombosis as an Initial Symptom of Malignant Tumor: A Case Report of Angiosarcoma in the Iliac Vein
por: Takahiro Matsui, et al.
Publicado: (2021) -
Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis
por: Jia Li, et al.
Publicado: (2021) -
Clinical implications of systemic and local immune responses in human angiosarcoma
por: Jason Yongsheng Chan, et al.
Publicado: (2021) -
Multifocal Epithelioid Hemangioendothelioma Complicated with Disseminated Intravascular Coagulation
por: Hiroaki Kimura, et al.
Publicado: (2021) -
Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. <i>Cancers</i> 2021, <i>13</i>, 3814
por: Markus Notter, et al.
Publicado: (2021)